Benitec Biopharma Long Term Debt

Benitec Biopharma posts a long-term debt of $390K as of March 2026. That compares with $610K in the prior-year period — down 35.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Benitec Biopharma's long-term debt was $610K. The latest reading is $390K — a 35.7% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Benitec Biopharma's financial statement story. At $390K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BNTC's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Benitec Biopharma's other metric pages and overview cover the third.